Sign Up to like & get
recommendations!
0
Published in 2020 at "CNS Drugs"
DOI: 10.1007/s40263-020-00734-4
Abstract: Introduction Cognitive impairment is prevalent and debilitating among persons with multiple sclerosis (MS). While many pharmacologic treatments have shown good efficacy in reducing clinical relapses, brain lesions, and improving certain physical symptoms, their efficacy for…
read more here.
Keywords:
systematic review;
efficacy;
multiple sclerosis;
pharmacologic treatments ... See more keywords